Fe3O4-based PLGA nanoparticles as MR contrast agents for the detection of thrombosis. - Wikidata - wikimedia - TriplyDB

Fe3O4-based PLGA nanoparticles as MR contrast agents for the detection of thrombosis.

Fe3O4-based PLGA nanoparticles as MR contrast agents for the detection of thrombosis.

http://www.wikidata.org/entity/Q30362955

about

Recent advances and future prospects of iron oxide nanoparticles in biomedicine and diagnostics.Safety and efficacy of PLGA(Ag-Fe3O4)-coated dental implants in inhibiting bacteria adherence and osteogenic inducement under a magnetic field.

P2860

Q55001915-616A4108-9E15-4390-BFB8-3DFCB9A5EA9B Q55518744-3B136CBC-AEF2-49C3-9C25-AC722430E7F7

P2860

Fe3O4-based PLGA nanoparticles as MR contrast agents for the detection of thrombosis.

http://www.wikidata.org/entity/Q30362955

description

2017 nî lūn-bûn

@nan

2017 թուականի Փետրուարին հրատարակուած գիտական յօդուած

@hyw

2017 թվականի փետրվարին հրատարակված գիտական հոդված

@hy

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

name

Fe3O4-based PLGA nanoparticles as MR contrast agents for the detection of thrombosis.

@ast

Fe3O4-based PLGA nanoparticles as MR contrast agents for the detection of thrombosis.

@en

type

label

Fe3O4-based PLGA nanoparticles as MR contrast agents for the detection of thrombosis.

@ast

Fe3O4-based PLGA nanoparticles as MR contrast agents for the detection of thrombosis.

@en

prefLabel

Fe3O4-based PLGA nanoparticles as MR contrast agents for the detection of thrombosis.

@ast

Fe3O4-based PLGA nanoparticles as MR contrast agents for the detection of thrombosis.

@en

P1433

Q30362955-E533AC00-F1E4-4E41-98F6-ED05DF64DCE6

P1476

Q30362955-9A4C94B7-B929-4934-973D-363A7B3611E7

P2093

Q30362955-4D841398-99E9-4644-AC8D-3859E8449FD5

Q30362955-5966FA24-BFCC-4A58-A350-DA1883EF8278

Q30362955-62B16AB7-CDAD-4243-958C-5E87C3070535

Q30362955-72FE9C46-D83D-493A-B556-F1183CCAA0B9

Q30362955-7DC308EC-2645-4E00-B6A1-7D6507610ADA

Q30362955-832FEE97-ED98-4615-92C3-09C769407078

P2860

Q30362955-003FC1DD-894B-46A2-BAA5-933487A50865

Q30362955-00C3CA8F-AFB6-4E4F-82A4-7F4F540EFABE

Q30362955-02F5CDD4-61B9-4ABE-A6E3-F254B0F47333

Q30362955-04809CFB-3CA6-4BA9-8293-B98619EB2DBF

Q30362955-051A6E01-94B7-4D80-A16B-EDF077930D1E

Q30362955-05AC5328-17A7-44C4-8921-E100FFA21497

Q30362955-23192316-01F3-41F3-B082-6D803710990D

Q30362955-25344FE1-DCEE-40DE-BC00-4B7CDA7D2381

Q30362955-26D7579C-60C5-492C-B3EF-3578D20B58CF

Q30362955-3EECAB5C-ECC2-4642-B7C6-1C34752593C5

P304

Q30362955-6629A244-306C-46EA-9761-5B78A68096AB

P31

Q30362955-B568B066-262B-4BCB-BEB3-D3EAE22188B9

P356

Q30362955-31D27503-5B49-4EAF-AA1C-337A64B1B589

P407

Q30362955-22E60B6B-D105-48E5-896B-9F430716263F

P478

Q30362955-5B05B785-A24A-4077-B078-60B7CFCFA43E

P577

Q30362955-24B9F29C-10A8-4B7A-AE9A-41047D65F4C2

P698

Q30362955-619468DA-BDD1-4A0D-9EA9-B46161E28EBF

P921

Q30362955-21879A4C-A8D5-4DBE-A0BE-A7E7A4A54298

Q30362955-D6264482-444D-4516-8F70-443C19B2B055

P932

Q30362955-372FED1B-0777-41FE-A20C-CFCD956A3B7F

P356

P1433

International Journal of Nanomedicine

P1476

Fe3O4-based PLGA nanoparticles as MR contrast agents for the detection of thrombosis.

@en

P2093

Dajing Guo

http://www.w3.org/2001/XMLSchema#string

Jia Liu

http://www.w3.org/2001/XMLSchema#string

Jie Xu

http://www.w3.org/2001/XMLSchema#string

Jun Zhou

http://www.w3.org/2001/XMLSchema#string

Yu Zhang

http://www.w3.org/2001/XMLSchema#string

Zhigang Wang

http://www.w3.org/2001/XMLSchema#string

P2860

Thrombus-Targeted Theranostic Microbubbles: A New Technology towards Concurrent Rapid Ultrasound Diagnosis and Bleeding-free Fibrinolytic Treatment of Thrombosis.

Novel single-chain antibody-targeted microbubbles for molecular ultrasound imaging of thrombosis: validation of a unique noninvasive method for rapid and sensitive detection of thrombi and monitoring of success or failure of thrombolysis in mice

Preparation and characterization of gadolinium-loaded PLGA particles surface modified with RGDS for the detection of thrombus

A contrast agent recognizing activated platelets reveals murine cerebral malaria pathology undetectable by conventional MRI

Magnetic resonance molecular imaging of thrombosis in an arachidonic acid mouse model using an activated platelet targeted probe.

Construction and evaluation of Fe₃O₄-based PLGA nanoparticles carrying rtPA used in the detection of thrombosis and in targeted thrombolysis.

Superparamagnetic iron oxide nanoparticles for delivery of therapeutic agents: opportunities and challenges.

Are iron oxide nanoparticles safe? Current knowledge and future perspectives.

Effect of WOW process parameters on morphology and burst release of FITC-dextran loaded PLGA microspheres.

Molecular MRI of early thrombus formation using a bimodal alpha2-antiplasmin-based contrast agent.

P304

1113-1126

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.2147/IJN.S123228

http://www.w3.org/2001/XMLSchema#string

P407

P478

12

http://www.w3.org/2001/XMLSchema#string

P577

2017-02-09T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28223802

http://www.w3.org/2001/XMLSchema#string

P921

P932

5310639

http://www.w3.org/2001/XMLSchema#string